Skip Navigation

Gynecologic Oncology Program

About the Gynecologic Oncology Program

  • The Gynecologic Oncology Program at the Susan F. Smith Center for Women’s Cancers is a leader in research and care for patients with gynecologic cancer, including ovarian cancer, endometrial/uterine cancer, cervical cancer, vulvar cancer, and vaginal cancers, as well as gestational trophoblastic disease. We offer a seamless blend of medical, surgical, radiation, and pathology expertise and develop personalized approaches based on a woman’s specific type of cancer, whether it is early-stage or advanced.


  • Center for BRCA and Related Genes

    Mutations in BRCA1, BRCA2, and BRCA-related genes confer increased risk of certain cancers when inherited. These mutations can also be acquired by the cancers themselves. The Center for BRCA and Related Genes provides comprehensive care for patients with inherited and acquired mutations, including clinical therapeutic trials, trials of risk-reducing strategies, and studies of novel early detection markers. 

  • More Information

    new patient coordinators

    Becoming a Patient

    As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.

    cover supportive resources brochure

    Support Services and Amenities

    We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.

    patient ratings pie chart

    How Our Gynecologic Cancer Patients Rate Dana-Farber

    Take a look at our patient satisfaction survey results for our patients treated for gynecologic cancers.

  • More Information on Gynecologic Cancers

    Alan D. D'Andrea, MD
    News Releases
    10/8/2020

    Dana-Farber/Harvard Cancer Center wins prestigious federal grant to accelerate ovarian cancer research

    • Research
    • Ovarian Cancer
    News Releases
    9/25/2020

    Local women leaders hear about revolutionary developments in women’s cancer research at Dana-Farber Cancer Institute

    • BRCA
    • Susan F. Smith Center
    • Endometrial (Uterine) Cancer
    • Breast Cancer
    Insight Blog
    9/25/2020

    Ovarian Cancer Patient Benefits From New Research

    • Patient Stories, Adult
    • Ovarian Cancer
    • Gynecologic Cancer
    Insight Blog
    9/9/2020

    Ovarian Cancer Clinical Trial Helps Grandmother Feel Stable During a Difficult Year

    • Patient Stories, Adult
    • Ovarian Cancer
    • Gynecologic Cancer
    Panos Konstantinopoulos, MD, PhD
    News Releases
    8/12/2020

    Dana-Farber launches new Center for the prevention and treatment of BRCA-related cancers

    • BRCA
    • Ovarian Cancer
    • Gynecologic Cancer
    • Prostate Cancer
    • Pancreatic Cancer
    • Metastatic Breast Cancer
    • Breast Cancer
    Insight Blog
    7/8/2020

    What You Need to Know About Pap Smears

    • Susan F. Smith Center
    • Cervical Cancer
    • Gynecologic Cancer
    Insight Blog
    6/29/2020

    For Patient with Endometrial Cancer, Immunotherapy Proves the Perfect Move

    • Patient Stories, Adult
    • Immunotherapy
    • Endometrial (Uterine) Cancer
    • Gynecologic Cancer
    Illustration of a T lymphocyte cell attached to a cancer cell
    Publications
    6/18/2020

    Unexpected Benefits from Targeted Therapy

    • Precision Cancer Medicine
    • Ovarian Cancer
    • Breast Cancer
    Panos Konstantinopoulos, MD, PhD
    News Releases
    6/15/2020

    Drug with new approach on impeding DNA repair shows promise in first clinical trial

    • Precision Cancer Medicine
    • Ovarian Cancer